Level C· Early human research exploring benefitsRetrospective StudyEurope PMCOpen access

Addition of Platelet-Rich Plasma to Endorectal Advancement Flap Repair Does Not Enhance the Healing of Cryptoglandular Transsphincteric Fistulas

Bak MTJ., Bak MTJ., Arkenbosch JHC., Becker MAJ., Woude CJV., Vries AC.

Retrospective Study with a reported sample of 4 on Chronic Wound, Autoimmune Research, published in Dis Colon Rectum (2024) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
Dis Colon Rectum (2024)
Reported sample size
4
Source database
Europe PMC
PMID
38701430
PMCID
PMC11250094
DOI
10.1097/dcr.0000000000003312
Citations
5

Abstract (original English)

Background Endorectal advancement flap repair is often performed for the treatment of cryptoglandular transsphincteric fistulas. However, this procedure fails in approximately 1 of 4 patients. Based on its supposed healing properties, platelet-rich plasma might enhance the outcome of this procedure. Objective To evaluate and compare the short-term and long-term outcomes after endorectal advancement flap repair with and without platelet-rich plasma injection in patients with a cryptoglandular transsphincteric fistula. Design Retrospective cohort study. Setting Tertiary referral hospital for proctology in the Netherlands. Patients Consecutive patients with a cryptoglandular transsphincteric fistula. Inverse propensity score-weighted comparison was used to adjust for confounding and selection bias. Interventions Endorectal advancement flap repair with and without platelet-rich plasma injection. Main outcome measures Clinical fistula closure within 1 year without need for a reintervention (primary healing), clinical fistula closure within 1 year corrected for reinterventions (secondary healing), overall fistula healing within 1 year, and long-term outcomes assessed by a questionnaire. Results In total, 219 patients underwent an endorectal advancement flap repair. In 88 patients (40.2%), platelet-rich plasma was injected. No significant difference was observed in primary healing (67

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Surgical FlapsHumansRectal FistulaTreatment OutcomeRetrospective StudiesWound HealingAdultAgedMiddle AgedNetherlands

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research